The 6th Annual Conference on Precision Psychiatry: Innovation to Implementation is organized by the MGH Center for Precision Psychiatry and will take place from April 2 to April 3, 2027, at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, Massachusetts. Designed as a leading forum to examine breakthroughs in precision medicine applied to psychiatric research and clinical practice, the conference is offered in person with a virtual livestreaming option available for remote attendees.
The scientific program begins on Friday, April 2, with three concurrent, space-limited morning workshops exploring neuromodulatory interventions and predictive modeling, psychiatric artificial intelligence for clinicians, and multivariate genomics. The main conference program includes keynote addresses by Dr. Leanne Williams from the Stanford Center for Precision Mental Health and Dr. Steve Paul of Seaport Therapeutics and Third Rock Ventures. Across two days, leading international experts will present on therapeutic opportunities for precision psychiatry, neuroimaging biomarkers, the use of real-world evidence for prevention and intervention, dimensional diagnostic models and the DSM, therapeutic applications of psychedelics, neural circuit-based therapeutics, personalized treatment for mood disorders, ethical and clinical dimensions of artificial intelligence, and translating polygenic risk scores into clinical practice. The conference also highlights emerging investigators through the 2027 Emerging Innovators in Precision Psychiatry Awards.
Accreditation is provided through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital designates this live activity for a maximum of 15.50 AMA PRA Category 1 Credit™. In addition, the program meets criteria for 15.50 Nursing Contact Hours, 15.50 Social Workers continuing education hours, 15.50 Participation credits, and 15.50 Psychologists CE Credit.
Registration pricing for MDs and doctoral-level professionals is $550 for early bird registration on or before November 1, 2026, and $600 for regular registration after November 1, 2026. For other professionals, early bird registration is $450 and regular registration is $500. Registration for students, fellows, trainees, and interns is $150 with valid student identification. Each optional pre-conference workshop requires separate registration at $300.00 for professionals and $150.00 for trainees.
Fees (as published by the organiser): MDs/Doctoral-Level Professionals: Early Bird (on or before November 1, 2026): $550, Regular Registration (after November 1, 2026): $600; Other Professionals: Early Bird (on or before November 1, 2026): $450, Regular Registration (after November 1, 2026): $500; Students/Fellows/Trainees/Interns: Registration: $150 (not eligible for discounts; must provide proof of student ID); Optional Workshops (each): MDs/Doctoral-Level Professionals/Other Professionals: $300.00, Students/Fellows/Trainees/Interns: $150.00
Credits: 15.50 AMA PRA Category 1 Credit™
Faculty / directors: Jordan W. Smoller, MD, ScD, Director, MGH Center for Precision Psychiatry; Professor of Psychiatry, Harvard Medical School, Massachusetts General Hospital / Harvard Medical School; Leanne Williams, PhD, Professor of Psychiatry and Behavioral Sciences and Founding Director, Stanford Center for Precision Mental Health; Steve Paul, MD, Founder and Chair of the Board of Directors at Seaport Therapeutics and Venture Partner, Third Rock Ventures; Edward Boyden, PhD, Professor, Departments of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering, MIT; M. Brandon Westover, MD, PhD, Associate Professor of Neurology, Massachusetts General Hospital and Harvard Medical School; Susan Whitfield-Gabrieli, PhD, Tommy Fuss Endowed Chair in Precision Psychiatry; Associate Director, Center for Precision Psychiatry, Harvard Medical School; Rachel Yehuda, PhD, Chemers Neustein Family Professor of Trauma and Resilience, Vice Chair of Veterans Affairs, Icahn School of Medicine at Mount Sinai; Steven A. Kushner, MD, PhD, Professor of Psychiatry; Co-Director, Stavros Niarchos Foundation Center for Precision Psychiatry and Mental Health, Columbia University / New York State Psychiatric Institute; Joseph J. Taylor, MD, PhD, Medical Director of TMS; Assistant Professor of Psychiatry, BWH Center for Brain Circuit Therapeutics / Harvard Medical School; Andrea Cipriani, MD, PhD, NIHR Research Professor; Director, NIHR Oxford Health Clinical Research Facility, University of Oxford; Nicholas C. Jacobson, PhD, Associate Professor in Biomedical Data Science, Psychiatry, and Computer Science, Geisel School of Medicine at Dartmouth College; Rebecca Brendel, MD, JD, Director, HMS Center for Bioethics; Associate Professor of Psychiatry, Harvard Medical School; Jason Vassy, MD, MPH, MS, Director, Genomes2Veterans; Associate Professor of Medicine, VA Boston Health Care System / Harvard Medical School; Danielle Dick, PhD, Director, Rutgers Addiction Research Center (RARC) & Professor, Robert Wood Johnson Medical School; Marinka Zitnik, PhD, Associate Professor of Biomedical Informatics, Harvard Medical School